Strengthening specimen referral and transport networks in resource-limited settings: a Nigerian pilot to improve diagnosis The 46 th UNION world conference.

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

The Roadmap to Successful Xpert Implementation - 37 steps -
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
Improving diagnosis TB laboratory strengthening.
Dr R Ramachandran 5 th Joint International Monitoring Mission to Review NTP Thailand 5th JMM Thailand.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Rapporteur: Dr. Massimo Ghidinelli Facilitator: Dr.Elvira Teodora Wi
Accelerating PMDT scale up in Ethiopia
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
Country Progress Report Philippines
Early and Improved TB case detection through the use of GeneXpert technology in Nepal.
Integrating TB into PWID Services in Indonesia The Works in Progress Dr Siti Nadia, NAP Manager; Dr Dyah Erti Mustikawati, NTP Manager Melbourne AIDS Conference.
TB Screening in the Antenatal Care Setting in Malawi Symposium: Exploring the intersection between TB and maternal and neonatal health: from research to.
National TB/ Leprosy Programme Manager
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
Downloaded from Accelerate scaling up of TB/HIV activities in Tanzania Dr. N.G.SIMKOKO WHO/NTLP - Tanzania.
Action Plan Good Health Situation of Population in Capital of Myanmar Yangon Division By DR MYA THIDA AYE.
Monitoring and Evaluation Module 12 – March 2010.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Unit 10. Monitoring and evaluation
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
Experience with Tb diagnostics and Scale up of services Botswana, Nigeria, and Tanzania Ernest Ekong, MD,MPH National Clinical Coordinator Harvard PEPFAR.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Large Hospitals DEWG – Group Work Report. Participants Indonesia Philippines South Africa Viet Nam Korea China Partners: KNCV, WHO, Gates.
June 30, 2010 TB Program Thailand MOPH – U.S. CDC Collaboration TB Project Implementation: Impact on NTP?
Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges Andrea Howard, M.D., M.S. 14 th Core Group Meeting of TB/HIV Working.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
High cost of Xpert MTB/RIF ® testing per tuberculosis case diagnosed at Partners in Hope Medical Center, a public private HIV care clinic in Lilongwe,
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
Module 8: Recording and reporting Global Laboratory Initiative – Xpert MTB/RIF Training Package.
Screening for TB among risk groups in Cambodia Dr. Mao Tan Eang, NTP Director National Center for TB and Leprosy Control, Cambodia TAG Meeting, 9-12 December.
Strengthening National Lab. Network for diagnosis of TB and HIV: Challenges and solutions. Nicholas Wambua MD; MPH; DTCE. Technical Advisor -Tuberculosis.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
H Bygrave L Triviño L Makakole Medecins sans Frontieres Lesotho Scott Hospital Morija TB/HIV Integration Lessons learned from implementation of a TB/HIV.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Intensified TB case finding and infection control in Tanzania – opportunities and challenges Denis Tindyebwa Technical Director EGPAF Tanzania.
Early TB case detection in pre-trial detention centers (SIZOs) and prison colonies in Ukraine 46 th Union World Conference on Lung Health Cape Town, South.
GLOBAL TB PROGRAMME Systematic screening for active TB – operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme.
TB and HIV integrated services at Martin Preuss Centre in Lilongwe, Malawi : “The Lighthouse Trust initiative” Dr Sam Phiri Executive Director Lighthouse.
Challenges of Intensified TB case finding among PLHIV : Kenyan experience Dr. J. Sitienei Ministry of Health Kenya.
The 16 th International Conference on AIDS & STIs in Africa, Addis Ababa Trends in HIV Seroprevalence among clients with newly diagnosed tuberculosis in.
Attrition between TB / HIV testing and linkage to care in South Africa’s correctional facilities. 01 December 2015 Vincent Zishiri, Salome Charalambous,
Gap Analysis: Tuberculosis Care in Malawi Round 11 proposal to the Global Fund to Fight AIDS, Tuberculosis and Malaria Africa 3: Team Malawi Arianna, Babatunde,
1. Screening and Management of TB among HIV cases 1.1 Ward Physicians Inform the HIV center regarding referrals of PLHIV with TB to TB Center 1.2 HIV.
Strengthening specimen referral and transport networks in resource-limited settings: a Nigerian pilot to improve diagnosis The 46 th UNION world conference.
1 NAME: TITLE:DATE:. 2 “One stop shop” for TB and HIV services improved initiation of antiretroviral therapy (ART) for co-infected patients in Eastern.
New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
Integrated Testing on the GeneXpert
Addressing the challenges and successes of expediting TB treatment among PLHIV who are seriously ill: experience from Kenya Masini E & Olwande C National.
TB- HIV Collaborative activities in Romania- may 2006 status
Field Testing of OMNI-gene TB Sputum Optimizer in Malawi
Integrated Testing on the GeneXpert
Country Progress Report Cambodia
Find and Treat All Missing Persons with TB
Progress in Implementation of TB/HIV Collaborative activities
Engagement of Informal Health Care Providers Increases Referrals and Successful Outcome of TB patients in Tribal District of India Using Mobile Technology.
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
5th edition NTP MANUAL OF PROCEDURES TB-DOTS Referral System
5th edition NTP MANUAL OF PROCEDURES Reporting
Multi-disease diagnostic integration
DSD and TB/HIV services in Zimbabwe
Presentation transcript:

Strengthening specimen referral and transport networks in resource-limited settings: a Nigerian pilot to improve diagnosis The 46 th UNION world conference on Lung health Cape Town, South Africa 2 nd – 6 th December 2015 S. Useni, S. Massaut, M. Gidado, J. Onazi, S. Gande, P. Nwadike, S. Kik

TB Situation – Nigeria (2015 Global TB Report) Population: 177,000,000 DOTS centers: 5,398 AFB microscopy centers: 1,515 Culture DST laboratories: 6 GeneXpert laboratories: 96 Incidence Rate: 322/100,000 Total notified cases 2014 all forms: 91,354 CNR all forms for TB 2014 (per 100,000): 15.4% HIV prevalence : 3.4 % TB/HIV co-infection: 19% (16,066 cases) ART centers : 491 (85% TB/HIV co-located) MDR among new TB cases: 2.9% MDR among previously treated TB cases: 14%

Why this pilot? Practical model to demonstrate feasibility of using Xpert MTB/RIF to ↑ TB diagnosis within routine HIV care setting Increase number of PLHIV tested for TB with Xpert & put on treatment Strengthen accessibility & quality of Xpert testing Inform policy & public health practices

The Pilot Model TB/HIV Services Intensified Case Finding Increase TB mindedness Strengthen R&R and Supervision Increase Access to Diagnostic Services Simplify care and treatment

Pilot timeline Nov-Dec 2013 Site Assessments Jan-Mar 2014 Model Design Apr-May Training and Preparation April/May-Dec Implementation Jan-May complete data collection and analysis

Geographical HIV prevalence by state National HIV prevalence – 3.4% National TB/HIV co-infection - 19% (16,066 cases) Nasarawa state Population 2,202,906 HIV Prevalence: 7.5% TB CNR: 128.2/100,000 Pilot Sites: Niger state Population 4,670,286 HIV Prevalence: 4.0% TB CNR: 35.9/100,000

Hub & Spoke Implementation XPERT Pilot Site Nasarawa State Lafia (Dalhatu Araf Specialist Hospital) Niger State Minna General Hospital Existing XpertNew Xpert Referral SiteKm 1PHC New Market5 2GH Obi26 3PHC Doma Road, Lafia10 4PHC Kwandere (DOTS)12 5Family Health Clinic (FAHCI)5 6MCH Care Centre, Shabu11 7GH, Akwanga30 8GH Nassarawa Eggon22 9Ola Hospital, Akwanga32 10ERCC Alushi34 Referral SiteKm 1General Hospital Kuta80 2Rural Hospital Sarkin Pawa84 3MMM Fuka60 4Devine Mercy Hospital25 5Sabon Titi PHC Tunga Minna25 6Town Clinic Bosso25 7General Hospital Kagara120 8General Hospital Wushishi128 9IBB Hospital15 10FMC Gawu130

Specimen Transportation: Set-up Nonexistent at the start of operations Required implementation Reinforced proper specimen collection procedures Trained on triple packaging (cold box) Transportation (dispatch) Registry Sputa only with Lab request forms Variable means of transit (fuel provided) Transportation twice per week from 10 peripheral sites Included RETURN of test results (TAT= 3-5 days)

Number of samples received from peripheral sites - based on presumptive TB register - 60% 41% 82% 40% 59%18%

Increase in PLHIVs tested for TB (Baseline vs Pilot) BaselinePilot Baseline: 15% of pres. TB cases were known PLHIV 418 PLHIV tested Pilot: 42% of pres. TB cases were known PLHIV 1534 PLHIV tested

Number of PLHIV tested remarkably increased 3-fold increase in HIV positives tested for TB 1,534 HIV positives tested in pilot period (84% of those registered) 418 HIV positives tested in baseline period (78% or those registered)

Successful Interventions Strengthened sputum transportation/referrals by reducing physical movement of clients. 60% (1,066 out of 2,665) of all sputum specimens that were tested with Xpert were from referral sites through hub and spoke model Improved access to diagnosis by geographic coverage for TB screening among PLHIV due to implementation of effective specimen referral system (at baseline, only 9 PLHIVs were tested with Xpert and in pilot period 782) Intensified case finding among PLHIV of 1.9 fold increase for notified bacteriological confirmed TB cases (at baseline 180 cases compared to pilot of 347 cases)

Overall Challenges Changing current testing paradigm (ALL asymptomatic new PLHIV) Maintaining overall understanding and motivation Coordination/communication - onsite/remotely - staff of separate programs and different interests Unpredictable interruptions - Industrial strike action by HCW from Jun. – Aug and Nov. – Dec (end pilot activities) - Political/civil unrest in Nasarawa state - Fire at Laboratory building in Niger state Insufficient tools and commodities - - No approval by NTP to print revised National tools - - Improvised existing tools to capture indicators - - Periodic stock out of cups, R&R tools, and cartridges

Future impact Lessons learned for scale up… raising awareness on GeneXpert among clinicians in relation to TB/HIV case management increasing access to GeneXpert testing through a well- functioning sputum sample transportation system strengthening supportive supervision While the model was successful according to the results, there is need to focus on: basic elements of TB/HIV case management data recording at the facility level

A well-coordinated sputum transportation system to Xpert testing sites minimizes the movement of patients and increases access to diagnostic and care services; not only for TB but also HIV. Conclusion

Acknowledgments KNCV TB Foundation FMoH – NTBLCP & NASCP MoH Niger state - TBCLP & SASCP MoH Nasarawa state - TBCLP & SASCP